Answers are grounded in this paper and cite their sources.
Obesity is a major global public health challenge. Induction of white adipose tissue (WAT) browning has emerged as a potential strategy to enhance energy expenditure and improve metabolic homeostasis. Paeoniflorin (PF), a natural monoterpene glycoside, exhibits diverse pharmacological activities; however, its effects on WAT browning remain unclear. This study aimed to investigate whether PF alleviates high-fat diet (HFD)-induced obesity and associated metabolic abnormalities by promoting WAT browning. Obesity was induced in C57BL/6 mice by HFD feeding, followed by oral administration of PF (100 or 200 mg/kg). Body weight, adipose tissue mass, blood glucose, serum insulin, and lipid profiles were evaluated. Adipocyte morphology and the expression of thermogenesis-related markers, including UCP1, PGC-1α, and PRDM16, were assessed by histological analysis, RT-qPCR, Western blotting, and immunofluorescence staining. Lipid accumulation was evaluated by Oil Red O staining. In vitro, 3T3-L1 cells were treated with PF during adipocyte differentiation to assess lipid accumulation and the expression of browning-related markers. The potential involvement of the AMPK/SIRT3 signaling pathway was further investigated using pharmacological inhibition of AMPK. PF treatment significantly attenuated HFD-induced obesity and metabolic abnormalities in a dose-dependent manner. Compared with the HFD group, final body weight was reduced by 5.6% and 9.8% following treatment with PF at 100 and 200 mg/kg, respectively. Fasting blood glucose levels were decreased by 22.3% and 35.3%, while fasting insulin levels were reduced by 34.2% and 62.6%, respectively. PF also markedly improved dyslipidemia, with serum TG, TC, and LDL-C levels reduced by 27.1%, 25.8%, and 25.0%, respectively, in the 100 mg/kg group and by 41.1%, 49.5%, and 42.6%, respectively, in the 200 mg/kg group. PF further reduced adipocyte hypertrophy and increased the expression of the browning-related markers UCP1, PGC-1α, and PRDM16 in inguinal white adipose tissue (iWAT). In differentiated 3T3-L1 adipocytes, PF reduced lipid accumulation, enhanced browning-related marker expression, and activated AMPK/SIRT3 signaling, whereas pharmacological inhibition of AMPK attenuated these effects. PF alleviates HFD-induced obesity and associated metabolic abnormalities, accompanied by enhanced iWAT browning and reduced lipid accumulation. These effects may be associated with activation of the AMPK/SIRT3 signaling pathway.
No takes yet. Share an insight, caveat, or question.
Mengyue et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: